SEC Form 4/A · accession 0001209191-18-033696

NANOPHASE TECHNOLOGIES Corp · NANX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.

Reporting owner

James A Henderson

Director

Period of report

May 23, 2018

Accepted (ET)

May 29, 2018 · 11:03 am EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000883107

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	holding	—	—		—	482,115	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Common Stock (right to purchase)^F1	$0.82	May 23, 2018	A	15,000	A	May 23, 2019	May 23, 2028	Common Stock	15,000	15,000	D
Common Stock (right to purchase)^F1	$1.36	holding	—	—	—	Jan 31, 2012	Jan 31, 2021	Common Stock	10,000	10,000	D
Deferred Common Stock^F2,F3,F4	—	holding	—	—	—	—	—	Common Stock	20,030	20,030	D
Common Stock (right to purchase)^F1	$0.52	holding	—	—	—	Feb 13, 2015	Feb 13, 2024	Common Stock	10,000	5,000	D
Common Stock (right to purchase)^F1	$0.44	holding	—	—	—	Feb 18, 2016	Feb 18, 2025	Common Stock	4,500	9,000	D
Common Stock (right to purchase)^F1	$0.42	holding	—	—	—	Feb 23, 2017	Feb 23, 2026	Common Stock	12,150	12,150	D
Common Stock (right to purchase)^F5	$0.90	holding	—	—	—	Nov 17, 2016	Nov 17, 2026	Common Stock	2,000	2,000	D
Common Stock (right to purchase)^F5	$1.05	holding	—	—	—	Nov 17, 2016	Nov 17, 2026	Common Stock	2,000	2,000	D
Common Stock (right to purchase)^F5	$1.18	holding	—	—	—	Nov 17, 2016	Nov 17, 2026	Common Stock	2,000	2,000	D
Common Stock (right to purchase)^F5	$0.84	holding	—	—	—	Nov 17, 2016	Nov 17, 2026	Common Stock	2,000	2,000	D
Common Stock (right to purchase)^F5	$1.85	holding	—	—	—	Nov 17, 2016	Nov 17, 2026	Common Stock	2,000	2,000	D
Common Stock (right to purchase)^F5	$1.10	holding	—	—	—	Nov 17, 2016	Nov 17, 2026	Common Stock	2,000	2,000	D
Common Stock (right to purchase)^F5	$0.99	holding	—	—	—	Nov 17, 2016	Nov 17, 2026	Common Stock	2,000	2,000	D
Common Stock (right to purchase)^F1	$0.68	holding	—	—	—	Feb 21, 2018	Feb 21, 2027	Common Stock	15,000	15,000	D

Explanation of responses

F1Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.
F2Each share of deferred common stock represents a right to receive one share of common stock.
F3The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.
F4Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 20,030 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensation Plan.
F5The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99.

Remarks

Amended to reflect transaction date of May 23, 2018. Originally filed as May 23, 2017.